Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
about
In silico identification of potential key regulatory factors in smoking-induced lung cancer.Novel C6-substituted 1,3,4-oxadiazinones as potential anti-cancer agents.RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src.Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesSnail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks Tumorigenesisc-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.Formation of the IGF1R/CAV1/SRC tri-complex antagonizes TRAIL-induced apoptosis in gastric cancer cells.Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer.Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.Src kinase inhibitor PP2 regulates the biological characteristics of A549 cells via the PI3K/Akt signaling pathwayHypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells
P2860
Q33776567-EB1C00AC-E883-4453-BC21-A24C253F3C49Q36562098-F27A139F-B727-4B12-9283-0D5B9331C120Q37044602-A9A14B22-4EA9-46B0-AF5D-31D85A5C3F3BQ37348159-F8574220-F7F8-4B80-AFD0-E814903C04BAQ38641329-D7A17A58-F621-4C0B-954D-BA3C62336B3BQ38726530-2F5D8173-80AD-47B8-BC5C-3A099069E317Q38768131-B33601F1-6B09-44DB-9E45-9F18BF61CC86Q47921552-B0150CBB-58AC-4A15-9894-53A0C27DDDFEQ49887912-7DF56797-8441-4919-B0AB-751ECDBD0706Q50005441-7200B921-22F1-4BBB-9E4D-D750593AC388Q51746396-F0866F19-B180-4F3D-93FF-D2B55326FC61Q52646119-CDDC72FC-3022-4BA9-A1EC-08B321CE6DF1Q57144456-B43B01E4-AF29-4B18-93D1-DE907A23BBE1Q58773797-E5212AD2-34C0-43BD-8445-C8C50EAFD622
P2860
Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@ast
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@en
type
label
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@ast
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@en
prefLabel
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@ast
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Targeting the insulin-like gro ...... of non-small cell lung cancer.
@en
P2093
Ho-Young Lee
Hye Jeong Yun
Hye-Young Min
Hyo-Jong Lee
Hyun-Ji Jang
J Jack Lee
Jaebeom Cho
Ji-Sun Lee
Seung-Hyun Oh
P2860
P2888
P356
10.1186/S12943-015-0392-3
P577
2015-06-04T00:00:00Z
P6179
1035856613